The method of high-performance liquid chromatography (HPLC) with diode array detector (DAD) was used and validated for the simultaneous determination of nine flavonoids (rutin, myricetin, quercitrin, quercetin, luteolin, genistein, kaempferol, apigenin, and isorhamnetin) in beagle dog plasma. Plasma sample was pre-treated with acetonitrile (containing 0.05% formic acid). Chromatographic separation was performed on a kromasil C18 column (250 × 4.6 mm, 5 µm) maintained at 35 °C. The mobile phase was a mixture of methanol and 0.2% formic acid with a step linear gradient. At 1.0 mL min−1 flow rate, the eluent of other eight flavonoids was detected simultaneously at 360 nm with good separation except genistein (detected at 254 nm). Under optimum conditions, the correlation coefficient between the peak area and the concentrations for each analyte was all above 0.999. The intra-day and inter-day precisions were less than 10% for all analytes. The limit of detection and the limit of quantification for the selected nine flavonoids were 0.006–0.03 and 0.02–0.12 g mL−1, respectively. The extracted recoveries of selected nine flavonoids were 74.02%–99.37%. The assay has been successfully applied to determine concentrations of nine flavonoids in plasma from beagle dog after being intravenously administrated Ginkgo biloba extract.
[1]. M.L. Chavez P.I. Chavez 1998 Hosp. Pharm. 33 1076.
[2]. K. Ndjoko J.L. Wolfender K. Hostettmann 2000 J. Chromatogr. B 744 249.
[3]. R.W. Stackman F. Eckenstein B. Frei D. Kulhanek J. Nowlin J.F. Quinn 2003 Exp. Neurol. 184 510.
[4]. M. Ellnain-Wojtaszek Z. Kruczynski J. Krasprzak 2003 Fitoterapia 74 1.
[5]. L.M. Goh P.J. Barlow C.S. Yong 2003 Food Chem. 82 275.
[6]. M.L. Chavez P.I. Chavez 1998 Hosp. Pharm. 33 658.
[7]. D.G. Watson E.J. Oliveira 1999 J. Chromatogr. B 723 203.
[8]. S.M. Boue C.H. Carter-Weintjies B.Y. Shih T.E. Cleveland 2003 J. Chromatogr. A 991 61.
[9]. O. Sticher 1999 Herbal Medicines for Neuropsychiatric Diseases, Ginkgo Preparations S. Kanba E. Richelson Biochemical, Pharmaceutical, and Medical Perspectives Seiwa Shoten Publishers Tokyo 83.
[10]. G.J. Yang P. Liu X.L. Qu M.J. Xu Q.S. Qu C.Y. Wang X.Y. Hu Z.Y. Wang 2007 J. Chromatogr. B 856 222.
[11]. F.M. Wang T.W. Yao S. Zeng 2003 J. Pharm. Biomed. Anal. 33 317.
[12]. I. Kazuo F. Takashi K. Yasuji 2001 J. Chromatogr. B 759 161.
[13]. I. Kazuo F. Takashi K. Yasuji 2003 J. Chromatogr. B 794 49.
[14]. Y. Zhao Y. Sun C. Li 2008 J. Am. Soc. Mass Spectrom. 19 445.
[15]. F.M. Wang M.Z. Wu L. Zhou T.W. Yao Y.H. Yu 2003 China Journal of Chinese Materia Medica 28 279.
[16]. Q.J. Yang G.Z. Wu W.J. Xue Y.N. Tang X.Q. Wu 2002 Herald of Medicine 21 687.
[17]. D. Tang Y. Yin Z. Zhang Y. Gao Y. Wei Y. Chen L. Han 2009 Acta Chromatogr. 21 483.
[18]. FoodDrug Administration 2001 Guidance for Industry: Bioanalytical Method Validation Center for Drug Evaluation and Research Rockville, MD 1–22.
[19]. M.J. Dubber I. Kanfer 2004 J. Pharm. Pharm. Sci. 7 303.
[20]. A.G. Jensen K. Ndjoko J.L. Wolfender K. Hostettmann F. Camponovo F. Soldati 2002 Phytochem. Anal. 13 31.
[21]. J.X. Chen Y. Zhang 2008 J. Chromatogr. Sci. 46 117.
[22]. D.Q. Tang Y.G. Chen D.Z. Yang Y.Y. Gao A.B. Tang X.L. Jiang X.X. Yin 2010 Lat. Am. J. Pharm. 29 853.